The role of desmin alterations in mechanical electrical feedback in heart failure

• Published in: Life sciences (1973) 2020-01, Vol.241, p.117119-117119, Article 117119
• Main Authors: Chen, Lin, Wang, Li, Li, Xingyi, Wang, Can, Hong, Mingyang, Li, Yuanshi, Cao, Junxian, Fu, Lu
• Format: Article
• Language: English
• Subjects: Animals; Calcium - metabolism; Calpain - metabolism; Calpain-1; Cells, Cultured; Desmin; Desmin - genetics; Desmin - metabolism; Dipeptides - pharmacology; Disease Models, Animal; Electrocardiography; Feedback, Physiological; Gene Knockdown Techniques; Heart Failure - etiology; Male; MEF; Myocytes, Cardiac; NF-kappa B - genetics; NF-kappa B - metabolism; NF-κB; Rats, Sprague-Dawley; Sarcoplasmic Reticulum Calcium-Transporting ATPases - genetics; Sarcoplasmic Reticulum Calcium-Transporting ATPases - metabolism; SERCA2; Tachycardia, Ventricular - complications; Tachycardia, Ventricular - physiopathology
• ISSN: 0024-3205; 1879-0631
• DOI: 10.1016/j.lfs.2019.117119

Mechanoelectric feedback (MEF) was related to malignant arrhythmias in heart failure (HF). Desmin is a cytoskeleton protein and could be involved in MEF as a mechanoelectrical transducer. In this study, we will discuss the role of desmin alterations in mechanical electrical feedback in heart failure and its mechanisms. We used both an in vivo rat model and an in vitro cardiomyocyte model to address this issue. For the in vivo experiments, we establish a sham group, an HF group, streptomycin (SM) group, and an MDL-28170 group. The occurrence of ventricular arrhythmias (VA) was recorded in each group. For the in vitro cardiomyocyte model, we established an NC group, a si-desmin group, and a si-desmin + NBD IKK group. The expression of desmin, IKKβ, p-IKKβ, IKBα, p-NF-κB, and SERCA2 were detected in both in vivo and in vitro experiments. The content of Ca2+ in cytoplasm and sarcoplasmic were detected by confocal imaging in vitro experiments. An increased number of VAs were found in the HF group. SM and MDL-28170 can reduce desmin breakdown and the number of VAs in heart failure. The knockdown of desmin in the cardiomyocyte can activate the NF-κB pathway, decrease the level of SERCA2, and result in abnormal distribution of Ca2+. While treatment with NF-κB inhibitor can elevate the level of SERCA2 and alleviate the abnormal distribution of Ca2+. Overall, desmin may participate in MEF through the NF-κB pathway. This study provides a potential therapeutic target for VA in HF.